CClinicalTrials.gg
CompletedNCT01607424RECOSUpdated Sep 3, 2015

Specific Cognitive Remediation for Schizophrenia

An interventional study of cognitive remediation in Schizophrenia, sponsored by Hôpital le Vinatier. Completed. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2015-09-03.

Sponsored by Hôpital le Vinatier · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
151
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Rationale:

Cognitive deficits are a core feature in schizophrenia. Conventional treatments (antipsychotic medication and psychological treatments) have limited effects so cognitive remediation programs were designed to alleviate the problems. Interventions typically involve a variety of exercises in a paper and pencil or a computerized format with a growing number of specialized computer programs now being developed. However, many of these programs lack specificity which does not allow an individual's specific needs to be addressed. More targeted interventions might increase the effects of therapy so RECOS - COgnitive REmediation for Schizophrenia - was developed to fit this gap.

Methods: This is a multicenter, randomized, controlled study comparing patients aged 18 to 45 years suffering from schizophrenia according to DSM-IV-TR. RECOS will be compared to an already validated program (CRT).

220 patients will be randomized as follows :

  • Arm 1 : RECOS (42 h)
  • Arm 2 : CRT (42 h) The recruitment is performed by psychiatrists in Lyon, Paris, Clermont-de-l'Oise, Niort, Bordeaux, Ville-Evrard and Lausanne.
02

Conditions studied

  • Schizophrenia

Browse trials for

Keywords

  • cognitive rehabilitation
  • schizophrenia
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 151 is above the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Hôpital le Vinatier is the lead sponsor of 106 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • men and women aged 18 to 45 years
  • French speaker or French schooling since 7 years
  • clinical stability
  • diagnosis of schizophrenia

Exclusion criteria

Exclusion Criteria:

  • visual or auditory disorder
  • history of neurological illness or trauma
  • alcohol or drug dependence
  • mental retardation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
151 participants (actual)

Study arms

  • Experimental
    RECOS: 42 hours CR, 14 week-treatment.

    RECOS(Cognitive Remediation for Schizophrenia) exercises were designed by SBT Company and adapted by Vianin et al (2007) for specific use in schizophrenia. It includes computer based and paper and pencil exercises that target 5 main cognitive functions. RECOS modules focus on the relevant cognitive domains, which have been recommended by the MATRICS consensus. Each exercise has 10 difficulty levels. Allocation of the training modules in RECOS was determined according to the standard scores obtained in the comprehensive neuropsychological assessment. Each patient participated in the module corresponding to his/her most altered cognitive area.

    Behavioral: cognitive remediation

  • Active comparator
    CRT: 42 hours CR, 14 week-treatment

    CRT (Cognitive Remediation Therapy) exercises are the ones used by Wykes et al (1999). The CRT method consists of 3 modules: flexibility, memory (A and B) and planning (A and B). Each module involves a series of paper and pencil exercises with parallel forms providing with gradual difficulty.

    Behavioral: cognitive remediation

Interventions

  • Behavioralcognitive remediation

    RECOS: cognitive remediation for schizophrenia CRT: cognitive remediation therapy

06

What researchers measure

Primary outcomes

  1. Change from baseline in executive functioning at week 12

    BADS(Behavioral Assessement of Dysexecutive Functions) total score

    Time frame: week 12

Secondary outcomes

  1. Change from baseline in executive functioning, attention, memory and visuospatial abilities at week 12

    comprehensive neuropsychological assessment

    Time frame: week 12

  2. Change from baseline in symptoms at week 12

    PANSS (Positive And Negative Symptoms Scale)

    Time frame: week 12

  3. Change from baseline in self-esteem at week 12

    Rosenberg scale

    Time frame: week 12

  4. Change from baseline in insight at week 12

    Birchwood scale

    Time frame: week 12

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Franck N, Duboc C, Sundby C, Amado I, Wykes T, Demily C, Launay C, Le Roy V, Bloch P, Willard D, Todd A, Petitjean F, Foullu S, Briant P, Grillon ML, Deppen P, Verdoux H, Bralet MC, Januel D, Riche B, Roy P; Other members of the Cognitive Remediation Network; Vianin P. Specific vs general cognitive remediation for executive functioning in schizophrenia: a multicenter randomized trial. Schizophr Res. 2013 Jun;147(1):68-74. doi: 10.1016/j.schres.2013.03.009. Epub 2013 Apr 9. PubMed 23583327 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01607424
Lead sponsor
Hôpital le Vinatier
Collaborators
Centre hospitalier Saint Jean de Dieu - ARHM, Saint Anne's Hospital
Responsible party
Nicolas FRANCK, Pr (Professor (Claude Bernard University), head of department (Hôpital le Vinatier), principal investigator, Hôpital le Vinatier) — Principal investigator
First posted
May 30, 2012
Start date
Dec 2008
Primary completion
Oct 2011
Completion
Oct 2011
Last update
Sep 3, 2015

Study contacts

Nicolas Franck
principal investigator · Hôpital le Vinatier

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion